ImmunoGen
NASDAQ: IMGN
$5.15
+$0.25 (+5.1%)
Closing price July 6, 2022
The top analyst upgrades, downgrades and other research calls from Wednesday include AK Steel, Apple, Biogen, Electronic Arts, FitBit, Foot Locker, McDonald's and Pfizer.
4 years ago
Last Updated: 2 years ago
Cancer drug developer ImmunoGen posted sharply lower profits and revenues than analysts were expecting. The stock is taking a beating as a result.
4 years ago
Last Updated: 2 years ago
ImmunoGen saw its shares make a sharp turn downward on Thursday morning after the stock has seen an incredible year of trading so far.
4 years ago
Last Updated: 2 years ago
ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to a new 52-week high.
4 years ago
Last Updated: 2 years ago
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.
4 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and other research calls from Thursday include AutoZone, O'Reilly Automotive, Immunogen, Medtronic, Nike, OncoSec Medical and Schlumberger.
5 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and other research calls from Thursday include Amarin, American Express, Barrick Gold, Cameco, Groupon, ImmunoGen, JPMorgan and Whole Foods Market.
5 years ago
Last Updated: 2 years ago
ImmunoGen watched its stock make a handy gain after the firm announced that had amended its license agreements with Sanofi.
5 years ago
Last Updated: 2 years ago
October 14, 2016: Here are four stocks trading with relatively heavy volume among 57 equities making new 52-week lows in Friday’s session. On the NYSE, advancers led decliners by just better...
5 years ago
Last Updated: 2 years ago
July 15, 2016: Here are four stocks trading with relatively heavy volume among just 11 equities making new 52-week lows in Friday’s session. Volumes only rose above 1 million for two of the...
5 years ago
Last Updated: 2 years ago
July 14, 2016: Here are four stocks trading with relatively heavy volume among just 13 equities making new 52-week lows in Thursday’s session. Volumes did not rise about 1 million for any of...
5 years ago
Last Updated: 2 years ago
July 13, 2016: Here are four stocks trading with relatively heavy volume among 11 equities making new 52-week lows in Wednesday’s session. NYSE decliners led advancers by a small margin and...
5 years ago
Last Updated: 2 years ago
June 15, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Wednesday’s session. NYSE advancers led decliners by less than 2 to 1 while...
6 years ago
Last Updated: 2 years ago
June 14, 2016: Here are four stocks trading with relatively heavy volume among 97 equities making new 52-week lows in Tuesday’s session. NYSE decliners led advancers by about 2 to 1 while...
6 years ago
Last Updated: 2 years ago
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to June 7 in Chicago.
6 years ago
Last Updated: 2 years ago